In in vitro experiments, we found that celastrol can effectively inhibit the expression of the c-myc gene and reduce the expression of cyclin B1 and Cdc2 (CDK1) proteins, resulting in chondrosarcoma cell G2/M phase arrest and effective inhibition proliferation of chondrosarcoma cells [29, 41]. The gene discussed is MYC; the disease is chondrosarcoma.